🔎 Trials Near Me

Beranda › Kanker Paru Non-Sel Kecil › Ohio › Dayton

Uji klinis Kanker Paru Non-Sel Kecil di Dayton, OH

13 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Dayton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Dayton Physician LLC - Englewood, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 4 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Menerima pesertaFase 3
  • Miami Valley Hospital, Dayton
  • Miami Valley Hospital North, Dayton
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06890598

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Menerima pesertaFase 3
  • Local Institution - 0486, Centerville · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06561386

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Menerima pesertaFase 2/3
  • Dayton Physicians Network, Dayton
  • Kettering Medical Center, Kettering · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06712316

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Menerima pesertaFase 2/3
  • Kettering Health Cancer Center - Main Campus, Kettering · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT04613596

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 4 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 3 lainnya
18 Minutes · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 3 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Dayton Physician LLC - Englewood, Dayton
  • Greater Dayton Cancer Center, Kettering · 5 mi jauhnya
  • Kettering Medical Center, Kettering · 5 mi jauhnya
  • dan 2 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Research Site 131, Dayton
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05914116

Uji klinis Kanker Paru Non-Sel Kecil di kota lain

Studi lain di Dayton

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.